Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Cancer control interventions for low and middle-income countries
Dr Ophira Ginsburg and Dr Rengaswamy Sankaranarayanan
Cancer control interventions for low and middle-income countries ( Dr Ophira Ginsburg and Dr Rengaswamy Sankaranarayanan )
28 Jan 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
Where have we got to with cancer treatment? ( Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands )
27 Jan 2020
VITAL trial: Safety of vosaroxin and infusional cytarabine for frontline treatme...
Dr Stephen Strickland - Vanderbilt University Medical Center, Nashville, USA
VITAL trial: Safety of vosaroxin and infusional cytarabine for frontline treatment of AML ( Dr Stephen Strickland - Vanderbilt University Medical Center, Nashville, USA )
27 Jan 2020
Highlights from BGICC 2020
Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from BGICC 2020 ( Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020
An overview of breast cancer in Malaysia
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
An overview of breast cancer in Malaysia ( Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia )
27 Jan 2020
CAR-T cell therapy for ALL: Current challenges and future approaches
Dr Sara Ghorashian - University College London, London, UK
CAR-T cell therapy for ALL: Current challenges and future approaches ( Dr Sara Ghorashian - University College London, London, UK )
23 Jan 2020
Considerations for treatment sequencing in B-ALL
Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany
Considerations for treatment sequencing in B-ALL ( Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany )
23 Jan 2020
Long-term toxicities in paediatric ALL
Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark
Long-term toxicities in paediatric ALL ( Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark )
23 Jan 2020
BLAST: Blinatumomab for minimal residual disease in patients with ALL
Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
BLAST: Blinatumomab for minimal residual disease in patients with ALL ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )
23 Jan 2020
The new era of ALL treatment
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
The new era of ALL treatment ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jan 2020
Safety considerations for inotuzumab in patients with relapsed/refractory ALL
Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, U...
Safety considerations for inotuzumab in patients with relapsed/refractory ALL ( Prof David Marks - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
23 Jan 2020
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020